June 10‚ 2010
Anthera Pharmaceuticals Updates Its Lupus Scientific Advisory Board ...read more
June 3‚ 2010Anthera Pharmaceuticals Promotes Colin Hislop, M.D. to Chief Medical Officer ...read more
May 6‚ 2010Anthera Pharmaceuticals First Quarter 2010 Financial Report ...read more
May 3‚ 2010Anthera Pharmaceuticals Announces Additional Data from FRANCIS Study ...read more
April 28‚ 2010Anthera Announces First Quarter 2010 Financial Report and Conference Call ...read more
April 26‚ 2010Anthera Pharmaceuticals to Present at Deutsche Bank Securities’ 35th Annual Health Care Conference ...read more
April 6‚ 2010Anthera Pharmaceuticals Announces Closing of Underwriters' Exercise of Over-Allotment Option ...read more
March 23‚ 2010Anthera Pharmaceuticals Welcomes Georgina Kilfoil as Senior Vice President of Product Development and Clinical Operations ...read more
March 4‚ 2010Anthera Pharmaceuticals Completes Initial Public Offering ...read more
February 8‚ 2010Anthera Pharmaceuticals Announces Agreement with the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study ...read more
May 6‚ 2009Anthera’s Varespladib Meets Primary Endpoint In Phase 2 Francis Trial For The Treatment Of Acute Coronary Syndrome ...read more
March 24‚ 2009Following Encouraging Results Anthera To Continue Impacts Trial For The Prevention Of Acute Chest Syndrome In Patients With Sickle Cell Disease ...read more
